Key result
Liver-specific deletion of Plpp3 in apoE-/- mice fed a Western diet increased atherosclerotic lesion size at the aortic sinus by 35% compared to control mice.
Why the study?
Does liver-specific deletion of Plpp3 worsen atherosclerosis in apoE-/- mice?
Does liver-specific deletion of Plpp3 worsen atherosclerosis in apoE-/- mice?
Effect estimate: 35% increase
Absolute Event Rate: 479720% vs 355308%
p-value: p=0.031
Hepatic Plpp3 deletion worsens atherosclerosis development in apoE-/- mice on a Western diet, likely by increasing pro-atherogenic plasma lipids such as lactosylceramides and lysophosphatidic acids.
Supports hepatic Plpp3 protection in this model; hypothesis-generating for human atherosclerosis and should not change practice.
The PLPP3 gene encodes for a ubiquitous enzyme that dephosphorylates several lipid substrates. Genome-wide association studies identified PLPP3 as a gene that plays a role in coronary artery disease susceptibility. The aim of the study was to investigate the effect of Plpp3 deletion on atherosclerosis development in mice. Because the constitutive deletion of Plpp3 in mice is lethal, conditional Plpp3 hepatocyte-specific null mice were generated by crossing floxed Plpp3 mice with animals expressing Cre recombinase under control of the albumin promoter. The mice were crossed onto the athero-prone apoE −/− background to obtain Plpp3 f/f apoE −/− Alb-Cre + and Plpp3 f/f apoE −/− Alb-Cre − offspring, the latter of which were used as controls. The mice were fed chow or a Western diet for 32 or 12 weeks, respectively. On the Western diet, Alb-Cre + mice developed more atherosclerosis than Alb-Cre − mice, both at the aortic sinus and aorta. Lipidomic analysis showed that hepatic Plpp3 deletion significantly modified the levels of several plasma lipids involved in atherosclerosis, including lactosylceramides, lysophosphatidic acids, and lysophosphatidylinositols. In conclusion, Plpp3 ablation in mice worsened atherosclerosis development. Lipidomic analysis suggested that the hepatic Plpp3 deletion may promote atherosclerosis by increasing plasma levels of several low-abundant pro-atherogenic lipids, thus providing a molecular basis for the observed results.
No takes yet. Share an insight, caveat, or question.
Busnelli et al. (2017) studied Atherosclerosis (n=48). Liver-specific Plpp3 deletion vs. Plpp3f/f apoE-/- Alb-Cre- mice was evaluated on Atherosclerotic lesion size at the aortic sinus (Western diet) (35% increase, p=0.031). Liver-specific deletion of Plpp3 in apoE-/- mice fed a Western diet increased atherosclerotic lesion size at the aortic sinus by 35% compared to control mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: